All‐cause mortality (within 30‐days after surgery: any reported death) · adults undergoing non‐cardiac surgery
1 finding from 1 review
Acute stroke (within 30‐days after surgery: new focal neurologic deficit with signs and symptoms lasting longer than 24 hours) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists may leads to lower acute stroke (within 30‐days after surgery: new focal neurologic… compared with control (low certainty).
1 finding from 1 review
Cardiac mortality · adults undergoing non‐cardiac surgery
1 finding from 1 review
Myocardial infarction (within 30‐days after surgery: as detected on an electrocardiogram or trans‐oesophageal echocardiogram) · adults undergoing non‐cardiac surgery
1 finding from 1 review
Acute stroke (within 30‐days after surgery: new focal neurologic deficit with signs and symptoms lasting longer than 24 hours) · adults undergoing non‐cardiac surgery
1 finding from 1 review
All‐cause mortality (within 30‐days after surgery: any reported death) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in all‐cause mortality (within 30‐days after surgery: any reported death) compared with control (moderate certainty).
1 finding from 1 review
Cardiac mortality · adults undergoing cardiac surgery
1 finding from 1 review
Myocardial infarction (within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in myocardial infarction (within 30‐days after surgery: sudden death or… compared with control (moderate certainty).
1 finding from 1 review
Bradycardia (requiring pharmacological or pacemaker treatment during the period of study drug administration) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists probably leads to higher bradycardia (requiring pharmacological or pacemaker treatment during… compared with control (moderate certainty).
1 finding from 1 review
Hypotension (requiring treatment with inotropes or vasopressors during the period of study drug administration) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in hypotension (requiring treatment with inotropes or vasopressors… compared with control (low certainty).
1 finding from 1 review
Bradycardia (requiring pharmacological or pacemaker treatment during the period of study drug administration) · adults undergoing non‐cardiac surgery
1 finding from 1 review
Hypotension (requiring treatment with inotropes or vasopressors during the period of study drug administration) · adults undergoing non‐cardiac surgery
1 finding from 1 review